EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Serum Trefoil Factor-3 Predicts Survival in Peripheral Artery Disease

Gerfried Pesau iD, Bernhard Zierfuss, Clemens Hoebaus iD, Renate Koppensteiner, Gerit-Holger Schernthaner

Angiology · 2025

DOI: 10.1177/00033197241230973 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angiology, 2025. Verfasst von Gerfried Pesau und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Angiology, Department of Internal Medicine II, Medical University Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Peripheral Arterial Disease, Trefoil Factor-3. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medizinische Universität Wien.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trefoil factor 3 (TFF3) has been studied in processes leading to atherosclerosis. Data are scarce in manifest disease and missing in peripheral artery disease (PAD). This study aims to elucidate TFF3 with disease stages, degrees of atherosclerosis, and outcomes. TFF3 was measured in serum in 364 PAD patients without critical limb ischemia and mild to moderate chronic kidney disease (CKD). Mortality data were retrieved from the Austrian central death registry (median observation 9.6 years). Survival analyses were performed using Cox regression and the Kaplan–Meier method. A negative association between ankle-brachial index and TFF3 ( P < .001) was observed, while levels were similar in asymptomatic and symptomatic PAD. TFF3 increased with history of cardiovascular and cerebrovascular disease ( P < .001). TTF3 was associated with the estimated glomerular filtration rate (R = −0.617, P < .001) and urinary albumin-creatinine ratio (R = 0.229, P < .001). One SD increase in TFF3 showed a worsening in all-cause mortality (hazard ratio 1.68, CI 1.37–2.05) which persisted after multiple adjustment for cardiovascular risk, inflammatory, and angiogenetic markers (hazard ratio 1.35, CI 1.01–1.81). This study is the first to link TFF3 with both disease markers and outcomes in PAD. TFF3 demonstrated associations with renal function, PAD severity measured by ankle-brachial index, and additional atherosclerotic burden in PAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peripheral Arterial DiseaseTrefoil Factor-3HumansMaleFemaleAgedMiddle AgedBiomarkersRisk FactorsAustriaRegistriesPrognosisAged, 80 and overAnkle Brachial IndexGlomerular Filtration RatePredictive Value of Tests

Stichwörter der Autor:innen

atherosclerosismortalityperipheral artery diseaserenal diseasetrefoil factor 3

Substanzen

Trefoil Factor-3BiomarkersTFF3 protein, human

Autor:innen und Institutionen

  • Division of Angiology, Department of Internal Medicine II, Medical University Vienna, Vienna, Austria.

ORCID-Profile: Gerfried Pesau, Clemens Hoebaus

Förderung

  • Medizinische Universität Wien

Zitieren

APA

Pesau, G., Zierfuss, B., Hoebaus, C., Koppensteiner, R., & Schernthaner, G. H. (2025). Serum Trefoil Factor-3 Predicts Survival in Peripheral Artery Disease. Angiology. https://doi.org/10.1177/00033197241230973

Vancouver

Pesau G, Zierfuss B, Hoebaus C, Koppensteiner R, Schernthaner GH. Serum Trefoil Factor-3 Predicts Survival in Peripheral Artery Disease. Angiology. 2025. doi:10.1177/00033197241230973

BibTeX
@article{Pesau2025,
  author = {Pesau, Gerfried and Zierfuss, Bernhard and Hoebaus, Clemens and Koppensteiner, Renate and Schernthaner, Gerit-Holger},
  title = {Serum Trefoil Factor-3 Predicts Survival in Peripheral Artery Disease},
  journal = {Angiology},
  year = {2025},
  doi = {10.1177/00033197241230973}
}
Kostenlos starten →